Satellite Bio launches with new approach to bioengineering tissues

Submitted by admin on April 20, 2022 - 10:51am

Source:

BioPharma Dive

News Tags:

Headline:

snippet:

Backed by $110 million in venture funding, Satellite is led by Dave Lennon, formerly head of Novartis Gene Therapies.

Search form